Obstetrics & Gynecology

News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

New CDC Guidance Recommends Doctors Address IUD Insertion Pain for Patients

Doctor holding intrauterine device

It's well-documented that the insertion of an intrauterine device (IUD) can be painful. The Centers for Disease Control and Prevention have issued guidance recommending that doctors share options for pain management with their patients.

Dr. Aileen Gariepy, complex family planning specialist at Weill Cornell Medicine, discusses the new federal guidance with NPR's Ailsa Chang. Listen here.

White Coat Ceremony Welcomes Class of 2028

Medical students in white coats sitting in an auditorium.

Video of Class of 2028 White Coat Ceremony Highlights | Weill Cornell Medicine

Anisah Alladeen’s path to joining Weill Cornell Medical College’s Class of 2028 was almost 10 years in the making. 

Growing up in a Guyanese household in Queens, Alladeen witnessed firsthand the challenges immigrant communities face navigating the health care system. She often found herself encouraging her family and community members to seek timely medical treatment, helping to manage doctor’s appointments and ensure their access to quality care. Then in 2017, when Alladeen was in high school, her grandfather was diagnosed with end-stage renal disease and received a kidney transplant at NewYork-Presbyterian/Weill Cornell Medical Center. She often visited him at the hospital after school and, seeing how he was treated by the doctors and staff, something clicked.

Preclinical Study Explores Approved Drug for Ovarian Cancer

image of immune cells, stained brown, and ovarian cancer cells with various treatments

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers. The preclinical study, which combined the analysis of human ovarian tumors and animal models of the disease, was published on July 29 in Cancer Discovery, a journal of the American Association for Cancer Research.

Iron is essential for multiple cellular processes, so actively multiplying cancer cells often need larger amounts of it than normal cells. That’s especially true in ovarian cancers.

“We thought that was a perfect opportunity to try a new approach, because there is an FDA-approved iron-chelating drug called deferiprone that has been successfully used for other diseases with abnormal iron accumulation,” said senior author Dr. Juan Cubillos-Ruiz, the William J. Ledger, M.D., Distinguished Associate Professor for Infection and Immunology in Obstetrics and Gynecology at Weill Cornell Medicine. Iron-chelating drugs bind tightly to iron, preventing cells from using it.

Contact Us